# Tagomics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tagomics

- Industry: Biotechnology
- Headquarters: Cambridge, UK
- Website: www.tagomics.com
- Total disclosed funding: $9.4M
- Latest round: Seed (Jan 28, 2024)
- Investors on record: 7

## About

Established in 2020 and based in Cambridge, UK, Tagomics Limited provides molecular diagnostics, biomarker discovery, and disease understanding. The company was co-founded by Dr. Jack Kennefick (CEO) and Dr. Robert Neely. In February 2024, the firm raised GBP 6.7 million in venture funding led by investor Calculus Capital, with participation from investors Illumina Ventures, IQ Capital, Agilent Ventures, Mercia Asset Management, Meltwind, and OMX Ventures.

The company provides a proprietary multiomic platform that unlocks fragmentomic, epigenetic, and genomic features as well as other biological sources of disease-associated biomarkers. The platform of the company, when combined with cutting-edge bioinformatics and machine learning techniques, offers biological insights and a revolutionary breakthrough in genomics-based illness profiling and diagnostics.

The company plans to use the February 2024 funding to support the growth and development of its operations.

## Funding rounds

- Seed, Jan 28, 2024, $9.4M — Mercia Asset Management, Agilent Ventures, Calculus Capital, IQ Capital, Illumina Ventures, OMX Ventures, Meltwind

## Investors

- Mercia Asset Management (https://capitalatlas.ai/funds/mercia-asset-management) — Seed
- Agilent Ventures (https://capitalatlas.ai/funds/agilent-ventures) — Seed
- Calculus Capital (https://capitalatlas.ai/funds/calculus-capital) — Seed
- IQ Capital (https://capitalatlas.ai/funds/iq-capital) — Seed
- Illumina Ventures (https://capitalatlas.ai/funds/illumina-ventures) — Seed
- OMX Ventures (https://capitalatlas.ai/funds/omx-ventures) — Seed
- Meltwind — Seed